Authors: Exley, MA Bigley, NJ Cheng, O Tahir, SMA Smiley, ST Carter, QL Still, HF Grusby, MJ Koezuka, Y Taniguchi, M Balk, SP

Citation: Ma. Exley et al., CD1d-reactive T-cell activation leads to amelioration of disease caused bydiabetogenic encephalomyocarditis virus (vol 69, pg 713, 2001), J LEUK BIOL, 70(2), 2001, pp. 340-340

Authors: Exley, MA Bigley, NJ Cheng, O Tahir, SMA Smiley, ST Carter, QL Stills, HF Grusby, MJ Koezuka, Y Taniguchi, M Balk, SP

Citation: Ma. Exley et al., CD1d-reactive T-cell activation leads to amelioration of disease caused bydiabetogenic encephalomyocarditis virus, J LEUK BIOL, 69(5), 2001, pp. 713-718

Authors: Naumov, YN Bahjat, KS Gausling, R Abraham, R Exley, MA Koezuka, Y Balk, SB Strominger, JL Clare-Salzer, M Wilson, SB

Citation: Yn. Naumov et al., Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets, P NAS US, 98(24), 2001, pp. 13838-13843

Authors: Ali Tahir, SM Cheng, O Shaulov, A Koezuka, Y Bubley, GJ Wilson, SB Balk, SP Exley, MA

Citation: Sm. Ali Tahir et al., Loss of IFN-gamma production by invariant NK T cells in advanced cancer, J IMMUNOL, 167(7), 2001, pp. 4046-4050

Authors: Exley, MA Tahir, SMA Cheng, O Shaulov, A Joyce, R Avigan, D Sackstein, R Balk, SP

Citation: Ma. Exley et al., Cutting edge: A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses, J IMMUNOL, 167(10), 2001, pp. 5531-5534